Biología Sintética e Bioingeniería C2

Synthetic biology represents a revolutionary convergence of biology, engineering, and computer science that aims to design and construct new biological systems or redesign existing ones for useful purposes. Unlike traditional genetic engineering, which typically involves transferring individual genes between organisms, synthetic biology takes a more systematic approach, treating biological components as standardized parts that can be assembled into complex circuits and systems. This field draws inspiration from electrical engineering, where standard components like resistors and capacitors can be combined to build sophisticated circuits. Synthetic biologists seek to create analogous standard biological parts that can be reliably combined to program cellular behavior with predictable outcomes.

The foundational concept in synthetic biology is the abstraction hierarchy, which organizes biological components into different levels of complexity. At the most basic level are DNA parts such as promoters, ribosome binding sites, coding sequences, and terminators. These parts can be combined to form devices such as genetic circuits, sensors, and metabolic pathways. Multiple devices can then be integrated into systems that perform complex functions. This hierarchical organization allows engineers to work at different levels of abstraction, focusing on system design rather than getting lost in molecular details. The development of standardized parts and assembly methods has been crucial for making synthetic biology more predictable and reliable.

One of the most significant achievements in synthetic biology has been the creation of genetic oscillators, synthetic gene circuits that produce periodic oscillations in gene expression. The repressilator, developed in 2000, was the first synthetic genetic oscillator and demonstrated that complex dynamic behaviors could be engineered into living cells. This circuit consists of three repressor proteins that inhibit each other expression in a cycle, creating sustained oscillations. Genetic oscillators have since been refined and expanded, with applications ranging from controlling drug delivery to studying natural biological rhythms. The ability to engineer temporal dynamics in cells has opened new possibilities for therapeutic and biotechnological applications.

Metabolic engineering represents another major application area of synthetic biology. By redesigning metabolic pathways, scientists can microorganisms that produce valuable compounds such as pharmaceuticals, biofuels, and specialty chemicals. This approach has been used to engineer yeast strains that produce artemisinin, an important antimalarial drug, and bacteria that can convert plant biomass into biofuels. The advantage of using engineered organisms for production is that they can be grown in renewable feedstocks and often achieve higher yields and purity than traditional chemical synthesis methods. Metabolic engineering continues to expand as new tools for pathway optimization and regulation are developed.

Synthetic biology has made remarkable progress in creating minimal cells, organisms with the smallest possible genome that can still support life. The creation of Mycoplasma mycoides JCVI-syn3.0, a synthetic bacterium with only 473 genes, represented a landmark achievement in this direction. This minimal genome provides insights into the essential functions required for life and serves as a platform for adding new functions in a controlled manner. Understanding minimal genomes also has practical applications, as simpler organisms are easier to engineer and may be safer for industrial use. The quest to

Synthetic Biology and Bioengineering

Comentarios